Breaking News

Olon SpA Acquires Part of Ricerca Biosciences

Strengthens service offering of global CDMO and generics provider for research and manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Olon S.p.A. (www.olonspa.com), an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has acquired the chemical division of the contract research organization (CRO) and CDMO Ricerca Biosciences (www.ricerca.com) based in Concord, OH. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry, and will benefit the Ricerca Biosciences customer base by providing large scale manufacturing...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters